Qingdao Shengshi Zhiyang Import and Export Co., Ltd.
 
 
SHRED Mild Balanced Steady Lipolytic Composite Peptide
  • Brand:Shengshizhiyang
  • Model:1*1
  • Purity:99%
  • Cas:541-15-1
  • Createtime: 2026-07-09
  • Updatetime: 2026-06-30
Product Details
One box 10vials
useage Low-stimulation steady fat-loss blend for long-cycle mild lipid metabolism lab research
deliveryInfo
appearance White lyophilized powder
aliasen
supplyCapacity 100G/Day
harbor Hong Kong
minorder 1G
Payment method Alibaba, PayPal, USDT, bank card, Western Union remittance
Delivery date 10 days
Whatsapp +86 155 1138 8892

Name: SHRED

Alias: Standard Lipolytic Metabolic Blend, Moderate Fat Reduction Compound Formula
CAS Registry number: N/A (Compound peptide mixture)
Sequence: N/A
Molecular Formula: N/A
Molecular Weight: N/A
Purity: ≥99% (by HPLC)
Appearance: White lyophilized powder
Packing: 10mg*10vials/box
Product Group: Mild steady lipolytic composite peptide for daily metabolic regulation

Storage Conditions: Store at -20℃ in a dry, dark place; avoid repeated freeze-thaw cycles.


Brief Introduction:

SHRED is a mild balanced lipolytic composite peptide exclusively for laboratory research, designed for steady long-term fat metabolism regulation. It gently activates adipose lipolysis pathways, inhibits excessive lipid storage, improves resting metabolic rate without extreme metabolic stimulation. It reduces subcutaneous fat accumulation, optimizes liver lipid clearance, balances blood lipid levels, and avoids metabolic rebound and fatigue caused by high-potency fat-burning formulas. Suitable for long-cycle metabolic intervention research, widely applied in mild fat loss, basal metabolism maintenance, chronic lipid accumulation and daily metabolic balance laboratory studies.


Main Research Applications:

Mild steady lipolysis research: Study slow sustained adipocyte decomposition and gradual fat mass reduction mechanisms.
Basal metabolism maintenance research: Explore stable metabolic rate elevation without overstimulation pathways.
Chronic lipid accumulation research: Investigate long-term subcutaneous fat deposition improvement effects.
Metabolic rebound prevention research: Analyze post-lipolysis metabolic homeostasis stabilization.

Mild compound metabolic peptide research: Research balanced low-stimulation lipid regulation characteristics.


Note:
This product is for laboratory research use only. It is not intended for human or animal therapeutic use, clinical trials, or any form of in vivo administration without prior ethical approval and regulatory authorization.

Contact
Phone:+852 5426 4167
Tel:--
Whatsapp:852 5426 4167